The Journal of Pediatrics
Volume 149, Issue 5 , Pages 603-610.e1, November 2006

Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccine

  • Fred Zepp, MD

      Affiliations

    • Drs. Zepp, Knuf, and Habermehl have acted as consultants for GlaxoSmithKline/other pharmaceutical companies and have received travel grants or honoraria paid by healthcare companies within the past 3 years. None of the other authors in this paper have declared conflicts of interest.
    • Corresponding Author InformationReprint requests: Prof F. Zepp, Children’s Hospital, Johannes-Gutenberg-University, Langenbeckstrasse 1, 55101 Mainz, Germany.
    • ,
  • Markus Knuf, MD

      Affiliations

    • Drs. Zepp, Knuf, and Habermehl have acted as consultants for GlaxoSmithKline/other pharmaceutical companies and have received travel grants or honoraria paid by healthcare companies within the past 3 years. None of the other authors in this paper have declared conflicts of interest.
    • ,
  • Pirmin Habermehl, MD

      Affiliations

    • Drs. Zepp, Knuf, and Habermehl have acted as consultants for GlaxoSmithKline/other pharmaceutical companies and have received travel grants or honoraria paid by healthcare companies within the past 3 years. None of the other authors in this paper have declared conflicts of interest.
    • ,
  • Wilma Mannhardt-Laakmann, MD
    • ,
  • Barbara Howe, MD

      Affiliations

    • Drs Howe and Friedland are employees of GlaxoSmithKline and report ownership of equity or stock options.
    • ,
  • Leonard R. Friedland, MD

      Affiliations

    • Drs Howe and Friedland are employees of GlaxoSmithKline and report ownership of equity or stock options.

Children’s Hospital, Johannes Gutenberg University, Mainz, Germany; and GlaxoSmithKline Biologicals, King of Prussia, PA.

Received 21 November 2005; received in revised form 15 March 2006; accepted 9 June 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by GlaxoSmithKline Biologicals (study No. 100406).

 This clinical trial was registered at www.clinicaltrials.gov (No. NCT00263679).

PII: S0022-3476(06)00553-1

doi:10.1016/j.jpeds.2006.06.016

Refers to article:

  • Recommendation for an adolescent dose of tetanus and diphtheria toxoids and acellular pertussis vaccine: Reassurance for the future

    Scott A. Halperin
    The Journal of Pediatrics November 2006 (Vol. 149, Issue 5, Pages 589-591)

The Journal of Pediatrics
Volume 149, Issue 5 , Pages 603-610.e1, November 2006

Article Tools

* Image Usage & Resolution